CN102846899A - Storax tablet combination - Google Patents
Storax tablet combination Download PDFInfo
- Publication number
- CN102846899A CN102846899A CN2012103490785A CN201210349078A CN102846899A CN 102846899 A CN102846899 A CN 102846899A CN 2012103490785 A CN2012103490785 A CN 2012103490785A CN 201210349078 A CN201210349078 A CN 201210349078A CN 102846899 A CN102846899 A CN 102846899A
- Authority
- CN
- China
- Prior art keywords
- styrax
- storax
- rhizoma
- mouth
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000019382 gum benzoic Nutrition 0.000 title abstract 5
- 241001060310 Styracaceae Species 0.000 title abstract 4
- 235000001361 Styrax officinalis Nutrition 0.000 title abstract 4
- 235000000126 Styrax benzoin Nutrition 0.000 claims abstract description 17
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 7
- 239000004863 Frankincense Substances 0.000 claims abstract description 7
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims description 16
- 241000736148 Styrax Species 0.000 claims description 16
- 239000004870 Styrax Substances 0.000 claims description 16
- 241000717739 Boswellia sacra Species 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000000513 Santalum album Species 0.000 abstract 1
- 235000008632 Santalum album Nutrition 0.000 abstract 1
- 244000028419 Styrax benzoin Species 0.000 abstract 1
- 235000008411 Sumatra benzointree Nutrition 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 244000277583 Terminalia catappa Species 0.000 abstract 1
- 235000011517 Terminalia chebula Nutrition 0.000 abstract 1
- 229960002130 benzoin Drugs 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 230000004087 circulation Effects 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 238000010792 warming Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010075 Coma hepatic Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010073261 Ovarian theca cell tumour Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 201000001059 hepatic coma Diseases 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000001644 thecoma Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a storax tablet combination. The storax tablet combination is characterized by consisting of storax, borneol, benzoin, elecampane, rhizoma cyperi, sandalwood, clove, agilawood, roasted frankincense, rhizoma atractylodis macrocephalae, myrobalan, vermilion, ligusticum chuanxiong hort, fructus aurantii and salvia miltiorrhiza.
Description
One, technical field:
The present invention relates to one group of Styrax sheet.Mainly by following ingredients: Styrax, Borneolum Syntheticum, Benzoinum, the Radix Aucklandiae, Rhizoma Cyperi, Lignum Santali Albi, Flos Caryophylli, Lignum Aquilariae Resinatum, Olibanum are processed, the Rhizoma Atractylodis Macrocephalae, Fructus Chebulae, Cinnabaris, Rhizoma Chuanxiong, Fructus Aurantii, Radix Salviae Miltiorrhizae.
Two, technical background:
Effect: circulation of qi promoting is had one's ideas straightened out, warming middle-JIAO to relieve pain.
Cure mainly: constipation due to cold pathogen disease.Faint gnathospasma, syncope suddenly; Tongue is white, slow pulse; Sudden attack of pain in the chest and abdomen is very then fainted.Also control apoplexy, middle gas and the gas of row communicable subtropical diseases when experiencing, belong to constipation due to cold pathogen card person.
Modern times are mainly used in: we are mainly used in epidemic encephalitis type B, hepatic coma, angina pectoris, myocardial infarction etc. and belong to constipation due to cold pathogen and QI stagnated by cold person.
Three, summary of the invention:
The object of the present invention is to provide one group of Styrax sheet, to overcome the deficiency of known technology.
The present invention is achieved in that one group of Styrax sheet, and its special character is that it is to be made by following raw materials in part by weight: Styrax 1-3 part, Borneolum Syntheticum 1-3 part, Benzoinum 1-3 part, Radix Aucklandiae 1-3 part, Rhizoma Cyperi 1-3 part, Lignum Santali Albi 1-3 part, Flos Caryophylli 1-3 part, Lignum Aquilariae Resinatum 1-3 part, Olibanum are processed 1-3 part, Rhizoma Atractylodis Macrocephalae 1-3 part, Fructus Chebulae 1-3 part, Cinnabaris 0.5-1.5 part, Rhizoma Chuanxiong 1-3 part, Radix Salviae Miltiorrhizae 1-3 part, Fructus Aurantii 1-3 part.
Styrax: acrid in the mouth, warm in nature.GUIXIN, spleen channel.Having has one's ideas straightened out wards off dirty effect.
Borneolum Syntheticum: acrid in the mouth, hardship, cold nature.GUIXIN, spleen, lung meridian.Have and have one's ideas straightened out, the clearing away heat to alleviate pain effect.
Benzoinum: acrid in the mouth, slightly warm in nature.Have in the similar effect of Styrax, be used for the disease of closing in the coma.
The Radix Aucklandiae: acrid in the mouth, hardship, warm in nature.Return spleen, stomach, large intestine, gallbladder meridian.The effect that promoting the circulation of QI to relieve pain are arranged.
Rhizoma Cyperi: acrid in the mouth, little hardship, property is flat.Return liver, stomach warp.Depressed liver-energy dispersing and QI regulating is arranged, the effect of menstruction regulating and pain relieving.
Lignum Santali Albi: acrid in the mouth, warm in nature.Return spleen, stomach, lung meridian.Promoting the circulation of QI to relieve pain are arranged, the effect during eliminating stagnation is transferred.
Rhizoma Chuanxiong: acrid in the mouth, warm in nature.Return Liver Channel.Blood-activating and qi-promoting is arranged, the effect of wind-expelling pain-stopping.
Flos Caryophylli: acrid in the mouth, warm in nature.Return spleen, stomach, kidney channel.Warming middle-JIAO to send down the adverse QI is arranged, the warming the kidney to activate YANG effect.
Lignum Aquilariae Resinatum: acrid in the mouth, hardship, warm in nature.Return spleen, stomach, kidney channel.Promoting the circulation of QI to relieve pain are arranged, warming middle-JIAO warming the kidney, the effect of sending down the abnormal ascending QI.
Olibanum is processed: acrid in the mouth, hardship, and warm in nature.GUIXIN, liver, spleen channel.Promoting blood circulation and stopping pain is arranged, the effect of granulation promoting.
The Rhizoma Atractylodis Macrocephalae: bitter in the mouth, sweet, warm in nature.Return spleen, stomach warp.Invigorating the spleen and replenishing QI is arranged, dampness diuretic, the effect of strengthening superficial resistance to stop perspiration.
The Fructus Chebulae: bitter in the mouth, acid, puckery, property is flat.Return lung, large intestine channel.Relieving diarrhea with astringents is arranged, the effect of the sore-throat relieving of astringing the lung.
Cinnabaris: sweet in the mouth, cold in nature.The GUIXIN warp.Tranquillizing and allaying excitement is arranged, the effect of detoxifcation.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature.GUIXIN, pericardium, Liver Channel.Blood circulation promoting and blood stasis dispelling is arranged, removing heat from blood eliminating carbuncle, the effect that relieving restlessness is calmed the nerves.
Fructus Aurantii: hot, bitter, tepor.Return spleen, stomach warp.Promoting the circulation of QI to alleviate the stagnation in middle-JIAO is arranged, eliminate the effect of distension.
The side separates: Styrax, Borneolum Syntheticum, Benzoinum etc. are the product of causing resuscitation with aromatic drugs refreshment in the side, and wherein Styrax, Benzoinum can be warded off again dirty reducing phlegm, and current QI and blood is monarch drug altogether.Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Fructus Aurantii association monarch drug, blood-activating and qi-promoting, blood-activating analgetic; The Radix Aucklandiae, Lignum Santali Albi, Lignum Aquilariae Resinatum, Olibanum are processed, Flos Caryophylli, Rhizoma Cyperi are ministerial drug altogether, and with promoting QI circulation for relieving depression, dispersing cold for relieving pain is warded off dirtyization turbid, blood circulation promoting and blood stasis dispelling.Make mechanism of qi a surname logical, lifting is normal again, the smooth blood of gas, then turbid the falling of expectorant and key make and break.Rhizoma Atractylodis Macrocephalae air making-up and spleen enlivening, dampnessization is turbid; Fructus Chebulae's astringent therapy astringing QI; Two medicines and work incense drug compatibility can the QI invigorating convergence prevent the Xin Xiang healthy energy that too dissipates.The Cinnabaris tranquillization with heavy prescription, above is adjuvant drug all.All medicines are harmonious, and play altogether circulation of qi promoting and have one's ideas straightened out, the merit of warming middle-JIAO to relieve pain; The state of an illness is effectively treated and cured.
Four, the specific embodiment:
Below in conjunction with the specific embodiment, the present invention will be further described.
The specific embodiment: take by weighing first Benzoinum 500g, Radix Aucklandiae 500g, Rhizoma Cyperi 500g, Lignum Santali Albi 500g, Flos Caryophylli 500g, Olibanum is processed 500g, Rhizoma Atractylodis Macrocephalae 500g, Fructus Chebulae 500g, Rhizoma Chuanxiong 500g, Radix Salviae Miltiorrhizae 500g, Fructus Aurantii 500g, be total to 5500g, install with cloth bag, be condensed into paste with the multi-functional thickener of liquid, put into again the oven dry of Low-temp. electrothermal vacuum drier, can make concentrated dried medicine piece 700g-800g, take by weighing again Styrax 500g, Lignum Aquilariae Resinatum 500g, be total to 1000g, put under 160 ° of-200 ° of high temperature of microwave drying sterilization machine, operate 3-5 minute sterilizing, drying and stay and do substrate usefulness, Borneolum Syntheticum 500g, Cinnabaris 250g, 750g also does substrate and uses altogether.Put into together refrigerator-freezer after freezing 6 hours with concentrated medicine piece, be processed into fine powder with totally-enclosed pulverizer.Be pressed into 0.5 gram tablet bottling with rotary tablet machine more for subsequent use.
Instructions of taking: adult every day 3 times, 2-3 sheet after meal, body weight is at 45-60kg, each serving 2, more than 60 kilograms each serving 3, one after each meal.
This product is calculated the feeding white mice by every kg body weight 0.2 gram, and once a day, feeding is 30 days continuously, and the white mice physiological function is normal, checks that the white mice organ dysfunction is normal, does not find any unusual.
Taboo: contraindication in pregnancy.
Points for attention: the careful usefulness of person that has the allergic constitution.
Zhao so-and-so, woman, 62 years old.Suffer from coronary heart disease, take one group of Styrax sheet three times on the one, 2 after meal, take a course for the treatment of and cure.
Liu so-and-so, woman, 68 years old.Suffer from coronary heart disease, take one group of Styrax sheet three times on the one, 2 after meal, take a course for the treatment of and cure.
Yuan so-and-so, man, 67 years old.Suffer from angina pectoris, take one group of Styrax sheet, suck immediately during angina pectoris and take the 1-2 sheet, can take a turn for the better in buccal 5-30 minute.
Claims (1)
1. one group of Styrax sheet, it is characterized in that it is comprised of following weight portion: Styrax 1-3 part, Borneolum Syntheticum 1-3 part, Benzoinum 1-3 part, Radix Aucklandiae 1-3 part, Rhizoma Cyperi 1-3 part, Lignum Santali Albi 1-3 part, Flos Caryophylli 1-3 part, Lignum Aquilariae Resinatum 1-3 part, Olibanum are processed 1-3 part, Rhizoma Atractylodis Macrocephalae 1-3 part, Fructus Chebulae 1-3 part, Cinnabaris 0.5-1.5 part, Rhizoma Chuanxiong 1-3 part, Radix Salviae Miltiorrhizae 1-3 part, Fructus Aurantii 1-3 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103490785A CN102846899A (en) | 2012-09-13 | 2012-09-13 | Storax tablet combination |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103490785A CN102846899A (en) | 2012-09-13 | 2012-09-13 | Storax tablet combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102846899A true CN102846899A (en) | 2013-01-02 |
Family
ID=47394144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103490785A Pending CN102846899A (en) | 2012-09-13 | 2012-09-13 | Storax tablet combination |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102846899A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105902691A (en) * | 2016-05-13 | 2016-08-31 | 德施普科技发展温州有限公司 | Refreshing incense and preparation method thereof |
| CN111467680A (en) * | 2020-04-07 | 2020-07-31 | 王战威 | Chinese walnut with Chinese medicinal components and magnetic force and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1363331A (en) * | 2001-01-09 | 2002-08-14 | 杨孟君 | Nano storax medicine and its preparing process |
| CN101085081A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力制药股份有限公司 | Composition containing fructus aurantii for treating cardiovascular diseases and its preparation |
| CN102133288A (en) * | 2010-10-27 | 2011-07-27 | 宋爱民 | Chinese herba preparation for curing angina |
-
2012
- 2012-09-13 CN CN2012103490785A patent/CN102846899A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1363331A (en) * | 2001-01-09 | 2002-08-14 | 杨孟君 | Nano storax medicine and its preparing process |
| CN101085081A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力制药股份有限公司 | Composition containing fructus aurantii for treating cardiovascular diseases and its preparation |
| CN102133288A (en) * | 2010-10-27 | 2011-07-27 | 宋爱民 | Chinese herba preparation for curing angina |
Non-Patent Citations (1)
| Title |
|---|
| 周鲁 等: "中药复方治疗心绞痛的用药分析", 《时珍国医国药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105902691A (en) * | 2016-05-13 | 2016-08-31 | 德施普科技发展温州有限公司 | Refreshing incense and preparation method thereof |
| CN111467680A (en) * | 2020-04-07 | 2020-07-31 | 王战威 | Chinese walnut with Chinese medicinal components and magnetic force and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101991816B (en) | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases | |
| CN101209282A (en) | Preparation method of composite traditional Chinese medicine preparation for treating acquired immuno-deficiency syndrome | |
| CN102988920A (en) | Rhizoma corydalis tablets for treating dysmenorrhea | |
| CN102935196A (en) | Cough-relieving and sputum-reducing tablets | |
| CN102920870A (en) | Hawthorn capsule for improving digestion and harmonizing stomach | |
| CN102210839B (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN102846899A (en) | Storax tablet combination | |
| CN102716287A (en) | Qi depressing and asthma relieving capsule set | |
| CN102274482A (en) | Chinese medicinal preparation for treating diabetes | |
| CN102657795A (en) | Traditional Chinese medicine preparation for promoting postoperative incision healing | |
| CN102973873A (en) | Three kernel removing dampness tablets | |
| CN102872308A (en) | Snake gourd fruit tablets for promoting circulation of qi and removing stasis | |
| CN102861225A (en) | Radix ophiopogonis yin-nourishing and liquid engendering tablets | |
| CN102988926A (en) | Tri-jiao heat-clearing tablet | |
| CN101829306B (en) | A Chinese medicinal composition for treating hemiplegia, and its preparation method | |
| CN104873911A (en) | Traditional Chinese medicine for oral administration for adjunctively treating sepsis | |
| CN102727717A (en) | Medicine tablet for nourishing spleen and relieving liver | |
| CN102626446A (en) | Ulcerative carbuncle toxin expelling pharmaceutical composition | |
| CN102988597A (en) | Cortex moutan radicis stomach-clearing and blood-cooling tablet | |
| CN102716264A (en) | Medicinal compound tablet for warming channel and expelling cold | |
| CN102872318A (en) | Fritillary and trichosanthes capsule | |
| CN102716312A (en) | Group of tablets capable of stasis removing and collaterals dredging | |
| CN102847046A (en) | Magnolia officinalis-largehead atractylodes rhizome spleen-invigorating tablet | |
| CN102600420A (en) | Medicine composition for blood stasis and qi stagnation | |
| CN102716460A (en) | Evil-expelling and depression-resolving combined tablet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130102 |